Ian Robinson

Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain

Maulik D. Jhaveri, Denise Richardson, Ian Robinson et al. · Neuropharmacology · 2008 · 122 citations

Inflammation, Peroxisome Proliferator-activated Receptor-alpha, Cannabis Use +14

Sensitivity of carnitine acyltransferase I to malonyl-CoA inhibition in isolated rat liver mitochondria is quantitatively related to hepatic malonyl-CoA concentration <i>in vivo</i>

Ian Robinson, Victor A. Zammit · Biochemical Journal · 1982 · 102 citations · Full text

Malonyl-coa Inhibition, Oxidative Stress, Metabolic Syndrome +18

Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses

Ben Forbes, Raegan O’Lone, Philippa Pribul Allen et al. · Advanced Drug Delivery Reviews · 2014 · 90 citations · Full text

Inflammation, Macrophage Biology, Asthma +15

A 3D Human Airway Model Enables Prediction of Respiratory Toxicity of Inhaled Drugs In Vitro

Kinga Balogh Sivars, Ulf Sivars, Ellinor Hornberg et al. · Toxicological Sciences · 2017 · 87 citations · Full text

Asthma, Lung Deposition, Respiratory Toxicology +13

First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated

Sam Jackson, Albert F. Candia, Stephen Delaney et al. · Clinical Pharmacology & Therapeutics · 2017 · 29 citations